𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

✍ Scribed by Jens Modrof; Andreas Berting; Björn Tille; Andreas Klotz; Christina Forstner; Sandra Rieger; Claudia Aberham; Matthias Gessner; Thomas R. Kreil

Book ID
109143883
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
215 KB
Volume
0
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-by-dose virological and hematologic
Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection
✍ Julian W. Tang; June S.M. Lau; Stephanie Y.N. Wong; Jo L.K. Cheung; C.H. Chan; K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract A 42‐year‐old male with stage IV mantle cell lymphoma received chemotherapy and autologous peripheral blood stem cell transplantation. He developed pancytopaenia, and bone marrow examination indicated a parvovirus B19 (PVB 19)‐induced red cell aplasia, confirmed by virological tests. Mu

Chronic pure red cell aplasia caused by
Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin?A report of eight patients
✍ Koduri, Prasad Rao; Kumapley, Rudolf; Valladares, Jose; Teter, Caroline 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

The optimal management of chronic pure red cell aplasia caused by parvovirus B19 (B19-PRCA) in patients with AIDS is unclear. Our purpose was to determine the effects of intravenous immunoglobulin (IVIg) in the treatment of B19-PRCA in patients with AIDS. The patients were eight adults with AIDS adm